
Episode #12
Alcohol Liver Deaths, a VA Drug Trial, and Mobile Care That Finds You | Addiction News Weekly by Rehab.com
A JAMA review published August 4, 2026 documents that US deaths from alcohol-related liver disease nearly doubled between 1999 and 2022, a figure that complicates recent survey data showing declining alcohol use disorder rates. Rehab.com Chief Medical Officer Dr. Sylvie Stacy explains what the VA's new semaglutide trial actually represents, why three FDA-approved medications for alcohol use disorder remain underused, and how a network of mobile clinics in Massachusetts is reaching people conventional treatment has missed. Sources: https://pubmed.ncbi.nlm.nih.gov/42406571/ https://www.va.gov/minneapolis-health-care/news-releases/minneapolis-va-medical-center-named-one-of-18-va-sites-to-test-efficacy-of-glp-1-as-treatment-for-alcohol-use/ https://www.massgeneralbrigham.org/en/about/newsroom/press-releases/expanding-mobile-addiction-clinics

